Filing Details
- Accession Number:
- 0001103021-20-000138
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 16:30:36
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-19 16:30:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612372 | Mark W. Watson | C/O Biodelivery Sciences Intl, Inc. 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-17 | 13,000 | $5.18 | 52,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On August 17, 2020, the Reporting Person sold an aggregate of 13,000 shares of the Issuer's Common Stock at a weighted average price of $5.18 per share. The highest sale price for the Common Stock was $5.21 per share and the lowest sale price was $5.17 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
Billionaire Hedge Funds
